Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
1 Receptor
14%
30-day Mortality
8%
Adrenal Cushing Syndrome
22%
Age at Diagnosis
12%
All-cause Mortality
17%
Anemia
9%
Body Mass Index
14%
Bone Health
9%
Cabergoline
13%
Cabergoline Treatment
10%
Cancer Incidence
8%
Cancer Risk
22%
Cushing's Disease
41%
Cushing's Syndrome
100%
Diabetes Mellitus
21%
Dopamine Agonist
31%
Early Glaucoma
7%
Endogenous Cushing's Syndrome
40%
Etiology
21%
Glucagon-like
14%
Gonadal Axis
9%
Hazard Ratio
12%
Health Care Services
10%
High Prevalence
13%
High Risk
17%
Hospitalization
8%
Hyperprolactinemia
36%
Hypogonadal Men
9%
Hypogonadism
19%
Hypopituitarism
8%
Israel
15%
Macroprolactinoma
22%
Matched Cohort Study
26%
Mortality Risk
9%
National Cohort Study
16%
Pituitary
8%
Pituitary Adenoma
8%
Prolactin
27%
Prolactin Levels
7%
Prolactinoma
31%
Receptor Agonist
14%
Remission
33%
Remission Status
18%
Retrospective Cohort Study
49%
Socioeconomic Status
15%
Surgical Remission
8%
Syndrome Diagnosis
8%
Testosterone
10%
Weight Gain
8%
Working Diagnosis
11%
Medicine and Dentistry
Acromegaly
7%
All Cause Mortality
5%
Anemia
7%
Aromatase Inhibitor
7%
Atrial Fibrillation
7%
Atrial Flutter
7%
Blood Pressure Variability
7%
Body Mass Index
9%
Bone Disease
7%
Cancer
9%
Cancer Incidence
7%
Cataract
7%
Cohort Analysis
28%
Cushing Disease
33%
Cushing Syndrome
94%
Diabetes Mellitus
14%
Dopamine Agonist
7%
Elderly Patient
7%
Etiology
18%
Glaucoma
7%
Glucagon-Like Peptide-1 Agonist
7%
Glucocorticoid
8%
Hazard Ratio
6%
Hypercortisolism
6%
Hyperprolactinemia
8%
Hypertension
9%
Hypogonadism
6%
Hypopituitarism
7%
Infection
7%
Kidney Graft
7%
Leukocyte
7%
Leukocytosis
7%
Lung Transplantation
7%
Lymphocyte
5%
Malignant Neoplasm
10%
Morbidity
8%
Neutrophil
11%
Paget Bone Disease
7%
Pathophysiology
7%
Pituitary Adenoma
7%
Prevalence
12%
Prolactin
6%
Prolactinoma
14%
Retrospective Cohort Study
31%
Retrospective Study
8%
Socioeconomic Status
7%
Systolic Blood Pressure
7%
Treatment Outcome
7%
Venous Thromboembolism
7%
Zoledronic Acid
7%